| 2024-02-01 | Sale | RxSight, Inc. RXST | director | 28,250 0.0843% | $49.67 | $1.4M | +10.6% | |
| 2021-08-03 | RxSight, Inc. RXST | 31,250 0.1633% | $16.00 | $500,000 | -22.08% | |||
| 2020-12-01 | Sale | Glaukos Corporation GKOS | director | 50,000 0.111% | $67.97 | $3.4M | +9.4% | |
| 2019-08-21 | Sale | Edwards Lifesciences Corporation EW | director | 8,564 0.0041% | $221.65 | $1.9M | +1.08% | |
| 2019-08-20 | Sale | Edwards Lifesciences Corporation EW | director | 1,650 0.0008% | $222.98 | $367,919 | +0.93% | |
| 2018-11-19 | Sale | Edwards Lifesciences Corporation EW | director | 13,578 0.0065% | $149.92 | $2.04M | +24.8% | |
| 2018-11-15 | Sale | Glaukos Corporation GKOS | 54,050 0.1448% | $57.41 | $3.1M | +12.28% | ||
| 2018-11-13 | Sale | Glaukos Corporation GKOS | 28,950 0.0822% | $58.01 | $1.68M | +17.8% | ||
| 2018-02-09 | Sale | Edwards Lifesciences Corporation EW | director | 12,000 0.0055% | $122.24 | $1.47M | +14.6% | |
| 2016-11-29 | Sale | Edwards Lifesciences Corporation EW | director | 15,000 0.0071% | $84.01 | $1.26M | +30.3% | |
| 2016-11-17 | Sale | Glaukos Corporation GKOS | 60,000 0.1829% | $33.78 | $2.03M | +17.12% | ||
| 2016-05-31 | Sale | Glaukos Corporation GKOS | director | 68,116 0.2054% | $23.98 | $1.63M | +45.15% |